Display options
Cite
Soleimanifard S, Arjmand R, Saberi S, et al. P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER). Iran J Parasitol. 2014;9(3):423-8
Soleimanifard, S., Arjmand, R., Saberi, S., Khamesipour, A., Kazemi, M., Salehi, M., Akbari, M., & Hejazi, S. (2014). P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER). Iranian journal of parasitology, 9(3), 423-8.
Soleimanifard, Simindokht, et al. "P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER)." Iranian journal of parasitology vol. 9,3 (2014): 423-8.
Soleimanifard S, Arjmand R, Saberi S, Khamesipour A, Kazemi M, Salehi M, Akbari M, Hejazi S. P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER). Iran J Parasitol. 2014 Sep;9(3):423-8. PMID: 25678928; PMCID: PMC4316575.
Copy Download .nbib Format: NLM
Share it on

Iran J Parasitol. 2014 Sep;9(3):423-8.

P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER).

Iranian journal of parasitology

Simindokht Soleimanifard, Reza Arjmand, Sedighe Saberi, Ali Khamesipour, Mohammad Kazemi, Mansoor Salehi, Mojtaba Akbari, SeyedHossein Hejazi

Affiliations

  1. Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  2. Department of Parasitology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  3. Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
  4. Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  5. Deputy of Research, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  6. Skin Disease and Leishmaniasis Research Center, Department of Parasitology and Mycology, School of Medicine Isfahan University of Medical Sciences, Isfahan, Iran.

PMID: 25678928 PMCID: PMC4316575

Abstract

BACKGROUND: Leishmaniasis is a parasitic disease caused by different species of Leishmania parasites with a wide range of clinical manifestations. Antimonial compounds such as meglumine antimoniate (glucantime) are the first line drugs for the treatment of leishmaniasis. However, according to reports of the drug resistance of parasites, the efficacy of antimonial compounds is low. The ATP-binding cassette (ABC) proteins are present in all organisms and mediate the transport of vital elements through biological membranes. One of the important mechanisms of resistance in Leishmania parasites is the overexpression of ABC efflux pumps. P-glycoprotein A (pgpA) is a related gene for ABC transporter in Leishmania species. The aim of this study was to compare the pgpA expression in laboratory-induced resistant L. major (MRHO/IR/75/ER) and sensitive parasites.

METHODS: RNA extraction of promastigotes of sensitive and resistant clones was performed and total RNA was reverse transcribed. The real-time quantitative polymerase chain reaction (PCR) was used to assess RNA expression profiles and the expression levels were calculated using 2(-ΔCt) method.

RESULTS: The mean expression level of pgpA mRNA was 2.70 ± 0.51 in in sensitive Leishmania clone and 6.08 ± 1.50 in resistant Leishmania clone (P = 0.021).

CONCLUSION: The expression of pgpA gene in resistant strains of L. major was almost fivefold higher than those in susceptible strains. Therefore, this can be used in field isolates, i.e. overexpression of the gene can prove resistance in wild type field isolates.

Keywords: Leishmania major; P-glycoprotein A; Real-time RT-PCR; glucantime

References

  1. Mol Biol Int. 2011;2011:571242 - PubMed
  2. Eur J Dermatol. 2005 Mar-Apr;15(2):85-7 - PubMed
  3. J Infect Dis. 1999 Aug;180(2):564-7 - PubMed
  4. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10383-7 - PubMed
  5. Mol Biochem Parasitol. 1994 Nov;68(1):145-9 - PubMed
  6. Southeast Asian J Trop Med Public Health. 2011 May;42(3):502-8 - PubMed
  7. Am J Trop Med Hyg. 2008 Jul;79(1):69-75 - PubMed
  8. J Bioenerg Biomembr. 2001 Dec;33(6):469-74 - PubMed
  9. Exp Parasitol. 1997 Nov;87(3):275-82 - PubMed
  10. Iran Red Crescent Med J. 2011 Dec;13(12):863-7 - PubMed
  11. PLoS One. 2012;7(5):e35671 - PubMed
  12. Annu Rev Cell Biol. 1992;8:67-113 - PubMed
  13. Trop Med Int Health. 2001 Nov;6(11):899-905 - PubMed
  14. Iran J Parasitol. 2013 Jul;8(3):359-66 - PubMed
  15. PLoS Med. 2006 May;3(5):e162 - PubMed
  16. EMBO J. 1990 Apr;9(4):1027-33 - PubMed
  17. Int J Microbiol. 2010;2010:null - PubMed
  18. Arch Dermatol. 2006 Dec;142(12 ):1575-9 - PubMed
  19. Trop Med Int Health. 2001 Nov;6(11):849-54 - PubMed
  20. Int J Antimicrob Agents. 2003 Sep;22(3):352-7 - PubMed
  21. Science. 1985 Mar 22;227(4693):1485-7 - PubMed
  22. J Med Microbiol. 2007 Feb;56(Pt 2):143-53 - PubMed
  23. Parasitol Today. 1993 May;9(5):150-3 - PubMed

Publication Types